Analyst Research

Report Title Price
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: S&P Capital IQ Quantitative Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Auxilium Pharmaceuticals Inc Reaffirms FY 2012 Revenue Guidance-Conference Call

Wednesday, 9 Jan 2013 07:00am EST 

Auxilium Pharmaceuticals Inc announced that for fiscal 2012, it expects total net revenues of between $294 million and $314 million. 

Company Quote

0.25 +1.29%
23 Jul 2014